Use of panel tests in place of single gene tests in the cancer genetics clinic

Clinical Genetics

Volumn 88, Issue 3, 2015, Pages 278-282

  Yorczyk, A ^a   Robinson, L S ^a   Ross, Theodora S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Hereditary cancer; Next generation sequencing; Panel testing

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; TUMOR MARKER;

AFRICAN AMERICAN; ARTICLE; CANCER GENETICS; CONTROLLED STUDY; FAMILIAL CANCER; GENE MUTATION; GENETIC COUNSELING; GENETIC PANEL TESTING; GENETIC SCREENING; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CANCER; MUTATION RATE; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; ECONOMICS; FEMALE; GENETICS; HIGH THROUGHPUT SEQUENCING; MALE; MUTATION; NEOPLASMS; PROCEDURES;

BIOMARKERS, TUMOR; FEMALE; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MUTATION; NEOPLASMS;

EID: 84938831841     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12488     Document Type: Article

References (9)

1. Walsh T, Lee MK, Casadei S et al. Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci U S A 2010: 107: 12629-12633.
2. Ku CS, Cooper DN, Iacopetta B et al. Integrating next-generation sequencing into the diagnostic testing of inherited cancer predisposition. Clin Genet 2013: 83: 2-6.
3. Domchek SM, Bradbury A, Garber JE et al. Multiplex genetic testing for cancer susceptibility: out on the high wire without a net? J Clin Oncol 2013: 31: 1267-1270.
4. Walsh T, Casadei S, Lee MK et al. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci U S A 2011: 108: 18032-18037.
5. Mauer CB, Pirzadeh-Miller SM, Robinson LD et al. The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience. Genet Med 2014: 16: 407-412.
6. Murff HJ, Spigel DR, Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 2004: 292: 1480-1489.
7. National Comprehensive Cancer Network (NCCN) I: Genetic/Familial High-Risk Assessment: Breast and Ovarian, version 1 2014.
8. Woodage T, King SM, Wacholder S et al. The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet 1998: 20: 62-65.
9. Strul H, Barenboim E, Leshno M et al. The I1307K adenomatous polyposis coli gene variant does not contribute in the assessment of the risk for colorectal cancer in Ashkenazi Jews. Cancer Epidemiol Biomarkers Prev 2003: 12: 1012-1015.